Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein

Authors :: Kam M. Hui
Wei Peng Yong
Chin Hin Ng
Lingzhi Wang
Iain Beehuat Tan
Jianbiao Zhou
Qi Zeng
John Shyi Peng Yuen
Yeoh Khay Guan
Su Pin Choo
Soo-Chin Lee
Boon Cher Goh
Matthew C.H. Ng
Cheng Ean Chee
Nicholas Yan Zhi Tan
Joanne Ngeow
Joel Sng
Min Thura
Wee Joo Chng
Clarinda Chua
Sim Mei Yi
Eugene Shen Ann Yeo
Jie Li
Jean Paul Thiery
Edmund Chiong
Abdul Qader Omer Al-aidaroos
Henry Sun Sien Ho
Jimmy Bok Yan So
Abhishek Gupta
Source :: Nature Communications, Vol 12, Iss 1, Pp 1-1 (2021)
Publication Year :: 2021
Publisher :: Nature Portfolio, 2021.

Subjects :: Multidisciplinary
biology
business.industry
medicine.medical_treatment
Science
General Physics and Astronomy
General Chemistry
Immunotherapy
General Biochemistry, Genetics and Molecular Biology
Cancer immunotherapy
Drug development
medicine
biology.protein
Cancer research
Antibody
business
Tumor immunology

Tools